Crump, M <br/><br/>
High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 1993 
 - 704-11 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1993.11.4.704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Transplantation--adverse effects<br/>Combined Modality Therapy<br/>Etoposide--administration & dosage<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Survival Rate